Sirnaomics Ltd (2257.HK)

Healthcare | Biotechnology
Income Statement (Quarterly) 2026-04-08 2025-06-30 2025-03-31 2024-12-31
Revenue 81,000 81,000 40,500 434,000
Cost of Revenue 0 0 0 289,500
Gross Profit 81,000 81,000 40,500 144,500
Operating Expenses
R&D Expenses 0 0 0 0
SG&A Expenses 2,553,000 2,553,000 1,276,500 3,500,500
Operating Expenses 5,598,000 5,598,000 2,799,000 6,776,000
Operating Income -5,517,000 -5,517,000 -2,758,500 -6,631,500
Interest Expense 0 394,000 0 0
Income Before Tax -3,388,000 -3,388,000 -1,694,000 -3,376,000
Income Tax Expense 0 0 0 0
Net Income -3,698,000 -3,698,000 -1,849,000 -5,159,000
Per Share
EPS -0.04 -0.04 -0.02 -0.07
EPS Diluted 0.00 0.00 0.00 0.00
Income Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Revenue 1,778,000 397,000 0
Cost of Revenue 579,000 0 0
Gross Profit 1,199,000 397,000 0
Operating Expenses
R&D Expenses 0 0 0
SG&A Expenses 11,443,000 23,161,000 24,191,000
Operating Expenses 37,083,000 77,543,000 91,153,000
Operating Income -36,764,000 -77,146,000 -96,548,000
Interest Expense 1,049,000 0 798,000
Income Before Tax -50,245,000 -84,990,000 -97,378,000
Income Tax Expense 0 0 -9,079,000
Net Income -51,383,000 -78,691,000 -88,299,000
Per Share
EPS -0.66 -1.03 -1.16
EPS Diluted 0.00 0.00 0.00
Balance Sheet (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 11,769,000 23,884,000 105,229,000
Short Term Investments 0 20,043,000 0
Net Receivables 0 0 0
Inventory 0 0 0
Total Current Assets 19,459,000 58,718,000 117,249,000
Property Plant Equipment 7,621,000 15,484,000 29,522,000
Goodwill and Intangibles 730,000 823,000 919,000
Total Assets 28,329,000 75,787,000 163,931,000
Liabilities
Account Payables 4,599,000 3,868,000 4,892,000
Short Term Debt 951,000 1,179,000 1,751,000
Total Current Liabilities 37,226,000 13,013,000 14,227,000
Long Term Debt 7,107,000 7,666,000 9,005,000
Total Liabilities 44,333,000 51,330,000 52,371,000
Shareholders Equity
Retained Earnings 0 -472,639,000 -394,325,000
Total Shareholders Equity -1,680,000 40,196,000 122,006,000
Balance Sheet (Annual) 2024-12-31 2023-12-31 2022-12-31
Assets
Cash and Cash Equivalents 11,769,000 23,884,000 105,229,000
Short Term Investments 0 20,043,000 0
Net Receivables 0 0 0
Inventory 0 0 0
Total Current Assets 19,459,000 58,718,000 117,249,000
Property Plant Equipment 7,621,000 15,484,000 29,522,000
Goodwill and Intangibles 730,000 823,000 919,000
Total Assets 28,329,000 75,787,000 163,931,000
Liabilities
Account Payables 4,599,000 3,868,000 4,892,000
Short Term Debt 951,000 1,179,000 1,751,000
Total Current Liabilities 37,226,000 13,013,000 14,227,000
Long Term Debt 7,107,000 7,666,000 9,005,000
Total Liabilities 44,333,000 51,330,000 52,371,000
Shareholders Equity
Retained Earnings 0 -472,639,000 -394,325,000
Total Shareholders Equity -1,680,000 40,196,000 122,006,000
Cash Flow Statement (Quarterly) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -51,383,000 -78,691,000 -97,378,000
Depreciation & Amortization 5,556,000 6,159,000 3,933,000
Stock Based Compensation 2,666,000 3,550,000 413,000
Change in Working Capital 0 -2,740,000 -1,232,000
Operating Cash Flow -19,728,000 -70,292,000 -88,708,000
Investing Activities
Capital Expenditure 0 -1,742,000 -18,830,000
Investments 0 -1,742,000 -18,830,000
Investing Cash Flow 2,138,000 -5,350,000 -32,611,000
Financing Activities
Debt Repayment 0 0 0
Common Stock Issued/Repurchased 0 -5,432,000 72,000
Dividends Paid 0 0 0
Financing Cash Flow 5,817,000 -5,606,000 15,888,000
Summary
Free Cash Flow -19,836,000 -72,034,000 -107,538,000
Net Change in Cash -12,115,000 -81,345,000 -106,765,000
Cash Flow Statement (Annual) 2024-12-31 2023-12-31 2022-12-31
Operating Activities
Net Income -51,383,000 -78,691,000 -97,378,000
Depreciation & Amortization 5,556,000 6,159,000 3,933,000
Stock Based Compensation 2,666,000 3,550,000 413,000
Change in Working Capital 0 -2,740,000 -1,232,000
Operating Cash Flow -19,728,000 -70,292,000 -88,708,000
Investing Activities
Capital Expenditure 0 -1,742,000 -18,830,000
Investments 0 -1,742,000 -18,830,000
Investing Cash Flow 2,138,000 -5,350,000 -32,611,000
Financing Activities
Debt Repayment 0 0 0
Common Stock Issued/Repurchased 0 -5,432,000 72,000
Dividends Paid 0 0 0
Financing Cash Flow 5,817,000 -5,606,000 15,888,000
Summary
Free Cash Flow -19,836,000 -72,034,000 -107,538,000
Net Change in Cash -12,115,000 -81,345,000 -106,765,000